Get started
Author

Trine Lindsted

Observed name: T. Lindsted
OpenAlex ID: A5068897967
TGF-β IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer
2010 · Zhan Yao, Silvia Fenoglio, et al. · Proceedings of the National Academy of Sciences · 391
Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses
2018 · Clara Montagut, Guillem Argilés, et al. · JAMA Oncology · 141
PDF
Sym015: A Highly Efficacious Antibody Mixture against MET -Amplified Tumors
2017 · Thomas Tuxen Poulsen, Michael Monrad Grandal, et al. · Clinical Cancer Research · 49
Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform
2019 · Torben Gjetting, Monika Gad, et al. · mAbs · 34
PDF
Abstract 5629: Preclinical characterization of Sym023 a human anti-TIM3 antibody with a novel mechanism of action
2018 · Trine Lindsted, Monika Gad, et al. · Cancer Research · 18
Cetuximab Resistance in Squamous Carcinomas of the Upper Aerodigestive Tract Is Driven by Receptor Tyrosine Kinase Plasticity: Potential for mAb Mixtures
2016 · Ida Kjær, Trine Lindsted, et al. · Molecular Cancer Therapeutics · 18
An epigenetic switch regulates the ontogeny of AXL-positive/EGFR-TKi-resistant cells by modulating miR-335 expression
2021 · Debjani Pal, Polona Safaric Tepes, et al. · eLife · 15
Abstract 5626: Preclinical characterization of Sym022, a novel anti-LAG3 antibody
2018 · Michael M. Grandal, Maria C. Melander, et al. · Cancer Research · 8
Genotyping circulating tumor DNA identifies metastatic colorectal cancer (mCRC) patients highly sensitive to Sym004
2017 · C. Montagut Viladot, A. Bardelli, et al. · Annals of Oncology · 2
PDF
Abstract B029: Forging strong bidirectional preclinical and translational research for optimized drug development of Sym023 (S095018), a novel anti-TIM3 antibody
2025 · Julia Geronimi, Aditi Varthaman, et al. · Cancer Immunology Research · 1
Circulating tumor DNA profiling to identify patients with metastatic colorectal cancer with improved overall survival following Sym004 treatment.
2018 · Thomas Tuxen Poulsen, Michael Kragh, et al. · Journal of Clinical Oncology · 1
Preclinical characterization of S095029, a novel clinical-stage Fc-attenuated NKG2A-blocking antibody for cancer immunotherapy
2026 · Maria Carlsen Melander, Franziska Uhlenbrock, et al. · Frontiers in Oncology
PDF
Supplementary Tables and Figures. from Cetuximab Resistance in Squamous Carcinomas of the Upper Aerodigestive Tract Is Driven by Receptor Tyrosine Kinase Plasticity: Potential for mAb Mixtures
2023 · Ida Kjær, Trine Lindsted, et al.
Data from Cetuximab Resistance in Squamous Carcinomas of the Upper Aerodigestive Tract Is Driven by Receptor Tyrosine Kinase Plasticity: Potential for mAb Mixtures
2023 · Ida Kjær, Trine Lindsted, et al.
Data from Cetuximab Resistance in Squamous Carcinomas of the Upper Aerodigestive Tract Is Driven by Receptor Tyrosine Kinase Plasticity: Potential for mAb Mixtures
2023 · Ida Kjær, Trine Lindsted, et al.
Supplementary Figures and Tables from Sym015: A Highly Efficacious Antibody Mixture against MET-Amplified Tumors
2023 · Thomas Tuxen Poulsen, Michael Monrad Grandal, et al.
Supplementary information from Sym015: A Highly Efficacious Antibody Mixture against MET-Amplified Tumors
2023 · Thomas Tuxen Poulsen, Michael Monrad Grandal, et al.
Supplementary information from Sym015: A Highly Efficacious Antibody Mixture against MET-Amplified Tumors
2023 · Thomas Tuxen Poulsen, Michael Monrad Grandal, et al.
Data from Sym015: A Highly Efficacious Antibody Mixture against MET-Amplified Tumors
2023 · Thomas Tuxen Poulsen, Michael Monrad Grandal, et al.
Data from Sym015: A Highly Efficacious Antibody Mixture against MET-Amplified Tumors
2023 · Thomas Tuxen Poulsen, Michael Monrad Grandal, et al.
Author response: An epigenetic switch regulates the ontogeny of AXL-positive/EGFR-TKi-resistant cells by modulating miR-335 expression
2021 · Polona Safaric Tepes, Debjani Pal, et al. · eLife
Abstract 1219: Sym015, a novel antibody mixture targeting non-overlapping epitopes of MET, effectively inhibits growth of MET dependent tumors and overcomes resistance to a single monoclonal antibody
2016 · Thomas T. Poulsen, Michael M. Grandal, et al. · Cancer Research
Abstract 5455: Surface accumulation of receptor tyrosine kinases upon treatment with tyrosine kinase inhibitors and resulting enhancement of activity upon treatment cessation
2015 · Anne-Mette Bjerregaard, Michael V. Grandal, et al. · Cancer Research
Abstract 3585: HER3 and IGF1R are major mediators of both acquired and intrinsic cetuximab resistance in head and neck squamous cell carcinomas
2015 · Ida Kjaer, Trine Lindsted, et al. · Cancer Research
Works count: 24
Citation count: 678
H-index: 8
I10-index: 7
Year
Topic
Type